2019 Scientific Sessions

Anita W. Asgar, M.D., FSCAI

Anita W. Asgar, M.D., FSCAI
Institut de Cardiologie de Montreal
Outremont, QC
Canada


Biographical Sketch:
Dr. Anita Asgar is a full-time staff Interventional Cardiologist at the Montreal Heart Institute, and Associate Professor of Medicine at the Universite de Montreal. She specializes in transcatheter valve interventions, congenital interventions and cardiac MRI. Dr. Asgar was Co-Chair of the Canadian TAVR Guidelines and chairs the Working Group for Transcatheter Valve Therapy Quality Indicators in Canada. She has led the publication of two national quality reports for TAVR in Canada in 2016 and 2019. She is also the lead cardiologist for the transcatheter mitral/tricuspid valve program at the and lead Canadian enroller in the COAPT trial for MitraClip in secondary MR. Her research interests include the treatment and management of valvular heart disease and cost-effectiveness analysis and she is currently the Director of Transcatheter Valve Therapy Research at the Montreal Heart Institute.

Papers: